Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo - Zhang, Hui‐qiong; Xie, Xiao‐fang; Li, Gang‐min; Chen, Jun‐ren; Li, Meng‐ting; Xu, Xin; Xiong, Qiu‐yun; Chen, Guan‐ru; Yin, Yan‐peng; Peng, Fu; Chen, Yan; Peng, Cheng (Phytotherapy research, 2021)
Keywords: 1-Phosphatidylinositol 3-kinase; AKT protein; Anticancer properties; antineoplastic activity; Antitumor activity; Apoptosis; Biocompatibility; Bladder; Bladder cancer; carcinoma; Cell growth; Cell migration; Cervical cancer; Cervix; Cytotoxicity; Dendrobium chrysotoxum; erianin; Fluorescence; growth retardation; humans; Immune response; in vivo and vitro; interleukin-10; Interleukins; Kidneys; Kinases; Lung cancer; lung neoplasms; lungs; mice; Molecular docking; Nasopharyngeal carcinoma; necrosis; neoplasm cells; Nodules; Oral administration; phosphatidylinositol 3-kinase; phytotherapy; PI3K/Akt/mTOR pathway; Rapamycin; Spleen; Throat cancer; TOR protein; Toxicity; Tumor cells; Tumor necrosis factor; Tumor necrosis factor-TNF; urinary bladder neoplasms; uterine cervical neoplasms; Western blotting; Xenografts; Xenotransplantation